Samil Pharm said on January 29 that it has appointed Indian-born Villur Sundararajan Ram as its new chief executive officer.
Samil official said it is Korea's first pharmaceutical company to choose a non-Korean national as its chief.
Ram, 59, previously served as a finance executive of India-based Asia Paints for 35 years. In India, Ram was actively involved in marketing projects associat...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.